Medtech M&A: integration is key
As the tide of M&A activity continues to rise across the life sciences industry, LSIPR speaks to Tracy MacNeal of Ximedica on what’s driving the trend and the pitfalls to be aware of.
LSIPR 50 2018: Stephen Knight
Stephen Knight was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
LSIPR 50 2018: Kush Parmar
Kush Parmar was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
Two new weapons for defending Hatch-Waxman litigation
Mark Remus of Brinks Gilson & Lione discusses two patent-related challenges for generic pharmaceutical companies and how they might be overcome.
LSIPR 50 2018: Christopher Viehbacher
Christopher Viehbacher was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
LSIPR 50 2018: Iana Dimkova
Iana Dimkova was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the investment section, as LSIPR reports.
LSIPR 50 2018: Jean-François Formela
Jean-François Formela was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
LSIPR 50 2018: Frank Kalkbrenner
Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
LSIPR 50 2018: Bryan Roberts
Bryan Roberts was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
LSIPR 50 2018: Jim Tananbaum
Jim Tananbaum was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.
